Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 15.37% vs -16.83% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -1,255.56% vs -96.48% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -106.48% vs -72.66% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -9.52% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Jiangsu Aidea Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 15.37% vs -16.83% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 61.21% vs 87.58% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -1,255.56% vs -96.48% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 36.20% vs 28.82% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -106.48% vs -72.66% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 97.37% vs -94.16% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -9.52% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs 11.76% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






